Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
about
P1343
Potential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathwayIdentification of nucleus pulposus precursor cells and notochordal remnants in the mouse: implications for disk degeneration and chordoma formationFrequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisationAberrant hyperactivation of akt and Mammalian target of rapamycin complex 1 signaling in sporadic chordomasExtended ultrastructural characterization of chordoma cells: the link to new therapeutic optionsMicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET.Identification of repurposed small molecule drugs for chordoma therapy.Chordoma in the lateral medullary cistern in a patient with tuberous sclerosis: A case report and review of the literatureMapping of candidate region for chordoma development to 1p36.13 by LOH analysis.Analysis of the fibroblastic growth factor receptor-RAS/RAF/MEK/ERK-ETS2/brachyury signalling pathway in chordomas.Update on the cytogenetics and molecular genetics of chordomaCharacterization and analysis of human chordoma cell lines.Chordoma coexisting with Rathke's cleft cyst: case report and literature review.The prognostic value of Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23, and 17p13 in skull base chordomas.Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.Molecular characterization of putative chordoma cell linesThe biological basis for modern treatment of chordoma.Systemic therapy options for unresectable and metastatic chordomas.Recurrent chromosomal copy number alterations in sporadic chordomas.Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs.Current therapeutic options and novel molecular markers in skull base chordomas.Establishment and characterization of a primary human chordoma xenograft model.Establishment and characterization of a novel chordoma cell line: CH22.Frequent activation of EGFR in advanced chordomas.An integrated functional genomics approach identifies the regulatory network directed by brachyury (T) in chordoma.Novel therapeutic targets in chordoma.High-resolution whole-genome analysis of skull base chordomas implicates FHIT loss in chordoma pathogenesisHighly proliferative sellar chordoma with unusually rapid recurrence.Chordoma characterization of significant changes of the DNA methylation pattern.Comparison of human chordoma cell-kill for 290 MeV/n carbon ions versus 70 MeV protons in vitro.From notochord formation to hereditary chordoma: the many roles of Brachyury.Converging paths to progress for skull base chordoma: Review of current therapy and future molecular targets.Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin.Integrated miRNA-mRNA analysis revealing the potential roles of miRNAs in chordomas.Histone deacetylase inhibitors as potential therapeutic approaches for chordoma: an immunohistochemical and functional analysis.MicroRNA expression profiling reveals the potential function of microRNA-31 in chordomas.Molecular and clinical risk factors for recurrence of skull base chordomas: gain on chromosome 2p, expression of brachyury, and lack of irradiation negatively correlate with patient prognosis.Erlotinib inhibits growth of a patient-derived chordoma xenograft.
P2860
Q24648029-A32EF3B2-78F1-47A9-BB5A-0ADB5DDD8BDBQ24649542-E8F77458-5568-4856-8815-DF95EFA5F719Q24651310-B198B377-B84F-40C0-A7CC-B53E55ECB034Q24658269-BAA69C5E-0403-4D64-805B-01D408FAE1DFQ28542546-C15FFB80-6B61-41C9-864B-3352E13BC87CQ30414321-E7B21CF5-93F7-4C9C-84D9-CB809D3A932BQ30417586-2591D67E-F52C-47A9-ABED-1BFD29F62BCBQ33159005-634281F1-29AA-4EB5-A5AD-3BEF3711FFF5Q33271955-E4413F51-723D-47D7-A484-19932740F478Q33273364-DFDCBBBA-B534-457C-86D1-F4DEBA473915Q33273719-2B89CA3A-447F-4016-A2B6-8760231E74EBQ33273802-755732D2-70A5-4C8D-9598-533DF0F9C093Q33273814-F09EF924-F8D0-4150-8F5F-5B01FA197922Q33273878-CBE73BE5-AE98-4B30-9FDC-DF39B4F38A8DQ33274008-4D48F780-8169-431B-834E-3A9C8EA156C1Q33274011-D6D6E027-9F5E-42E1-B8B9-9CB578AB4531Q33274040-177269CE-A5D3-4E59-A175-A095FE5B1FB1Q33274086-77120F6A-7242-4710-8F29-9E4B733F2123Q33274146-998C5145-22BD-41A3-9C23-30262265B455Q33274149-B9918E2E-284E-47C0-908C-C9A2B04A691BQ33274171-D3682C8C-2AD8-4FD4-BAE3-8BCC1EFECC6BQ33274229-7FCA1129-E5EC-438E-89AA-E6F9114C473DQ33274278-6A3A092A-979F-4BEE-A332-BC73CAD0670BQ33274364-F62F7987-C1AA-4B03-B026-0BFEF82556C8Q33274441-900EE9D3-0DB1-4B16-A4A9-F79DE1CE7C1AQ33274473-10D88629-615B-4D2B-924B-D7921D256988Q33274526-0B9699D5-5183-460F-80F6-6D945FB91C29Q33274528-3580C79B-775C-4A13-91DB-1776C4585B09Q33274578-57CF2C8B-3190-4EB2-AC71-45406E6867ECQ33274605-F9009582-A106-4E42-A1D0-E23E863FDF75Q33274756-461A815A-3ED9-4ACE-A563-0B4CEC0DEB13Q33274772-FBD794A6-1C10-44EF-A6BE-8D824E06D9DBQ33274793-0688FB8D-F2E0-4E33-9D94-BD0159145A02Q33274821-A7861706-BFB9-44EC-8F19-45E39987852BQ33274834-1F188003-6E04-4968-91A8-6A704E3A4F41Q33274852-1F9D0662-6857-4BE2-B41B-A65649418609Q33274879-03318636-FA07-4DC9-BD0C-48F5451EEB38Q33274891-32BB2666-E83A-4ADF-B51E-A2A6364B0E91Q33274900-B098ACA0-5E5A-4A91-93C1-A5A7BF114D5BQ33275026-FFBA3733-D9DE-41B5-8690-C1A752A0A389
P2860
Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@ast
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@en
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@nl
type
label
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@ast
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@en
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@nl
prefLabel
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@ast
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@en
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@nl
P2093
P2860
P356
P1476
Genome-wide analysis of sixtee ...... man chordoma cell line, U-CH1.
@en
P2093
Brüderlein S
P2860
P304
P356
10.1002/GCC.1184
P4510
P577
2001-11-01T00:00:00Z